Epidemiology, presentation and long-term evolution of Graves' disease in children, adolescents and young adults with Turner syndrome

Horm Res Paediatr. 2014;81(4):245-50. doi: 10.1159/000357130. Epub 2014 Jan 31.

Abstract

Background: Epidemiological studies on the association between Turner syndrome (TS) and Graves' disease (GD) are sparse and no studies are available on the clinical course of GD in TS.

Objectives: To retrospectively investigate the GD prevalence in children and young adults with TS and to compare the GD course in patients with or without TS who were followed up for 4.1 ± 0.6 and 4.5 ± 3.7 years, respectively.

Design: The prevalence of GD in 408 TS patients was evaluated; presentation and evolution of GD under therapy were evaluated both in 7 patients with TS (group A) and in 89 patients without TS (group B).

Results: (a) The prevalence of GD in TS patients was 1.7%; (b) GD in TS was not associated with a specific karyotype; (c) with respect to group B patients, those of group A exhibited at presentation more advanced age, a lower fT4 level and more frequent association with other autoimmune diseases, and (d) the clinical course under methimazole therapy was not different in the two groups.

Conclusions: The prevalence of GD in children and young adults with TS is 1.7% and in TS patients, GD presents later and its clinical course is not different than in those without TS.

MeSH terms

  • Adolescent
  • Adult
  • Antithyroid Agents / therapeutic use
  • Child
  • Child, Preschool
  • Comorbidity
  • Female
  • Graves Disease / diagnosis*
  • Graves Disease / drug therapy
  • Graves Disease / epidemiology
  • Humans
  • Infant
  • Methimazole / therapeutic use
  • Prevalence
  • Retrospective Studies
  • Turner Syndrome / epidemiology*
  • Young Adult

Substances

  • Antithyroid Agents
  • Methimazole